A Different Kind of Comeback

A routine blood test revealed advanced liver disease, but a clinical trial at the VCU Stravitz-Sanyal Institute helped former major league pitcher Mike Christopher reclaim his health and the life he loves.

Give Today

1 in 3

U.S. adults are living with advanced liver disease, often without symptoms.

For 12 years, Mike Christopher lived his life to the rhythms of professional baseball — spring‑training rituals, bullpen antics, the jog to the mound, the familiar weight of the ball in his hand. 

As a major league relief pitcher in the 1980s and ’90s for the Los Angeles Dodgers, Cleveland Indians (now the Guardians) and Detroit Tigers, his job was simple in theory and demanding in practice: step in when the starter was done and close the game out. 

He was a specialist, controlled and precise, built to step in when the moment required.

But years after his playing career ended, a silent and serious disease threatened Christopher's health, and he was the one in need of a specialist. At VCU Health, a team of clinicians, researchers and experts recognized warning signs he couldn't see and acted with the expertise the moment required.

“I was willing to do anything. There's really only two choices when you get cirrhosis, and that's either a transplant or you pass away. I didn't want to take that chance – I had to do something.”
— Mike Christopher

A Disease You Don’t Feel

Liver disease doesn't send signals. It doesn't hurt. It often develops silently, without symptoms until significant damage is already done. It affects an estimated one in three adults in the U.S., many of whom don't know they have it. 

Christopher was one of them.

He didn't fit anyone's picture of a seriously ill patient. Decades removed from baseball, he was back where he’d grown up in Church Road, Va., staying busy with family and friends. He had built a career in construction with his father, uncles and father-in-law and still took on the occasional homebuilding project in retirement.

It started with a standard primary care appointment and routine blood work. His family physician reviewed his labs and noted elevated liver enzymes. 

But Christopher felt fine. No pain or fatigue, nothing that hinted at trouble.

Still, his doctor encouraged him to see a specialist to rule out anything serious and recommended a visit to the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. Just a 45-minute drive from his home, the institute could offer a closer look at what was behind the abnormal results.

“Normally I would have said, no. But for some reason that day, I just said, ‘Yeah, I'll be glad to go,’” Christopher said.

There was little reason for him to think anything was wrong. The appointment felt more precautionary than urgent.

At VCU Health, he underwent routine entry scans, standard tools to understand and measure his liver health. The results confirmed the concern his primary care physician had raised. The scarring in his liver was significant. Christopher was diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD). The disease was advanced scarring in his liver, well past the point where monitoring can help and firmly into the stage of managing serious risk.

If it progressed, a liver transplant would be in his future. 

He and his wife, Pam, sat with the news, stunned by what they heard. At that time, there was no FDA-approved treatment for his condition. 

“I was willing to do anything,” Christopher said. “There's really only two choices when you get cirrhosis, and that's either a transplant or you pass away. I didn't want to take that chance – I had to do something.”

The diagnosis reframed how he thought about the years ahead. Retirement was no longer about what he wanted to do next, it was about preserving the time to do it.

Mike Christopher

A routine primary care visit led to an unexpected diagnosis for former professional baseball player Mike Christopher. Specialists at VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health identified advanced liver disease and connected him with treatment and research opportunities. Photo: Daniel Sangjib Min

Coordinated Care with Options

At the Stravitz-Sanyal Institute, liver care and research work side by side. It’s a global leader in treating the full spectrum of liver disease, from early detection to transplant, and one of few places regionally where patients can access clinical trials. It’s an environment where hepatologists, surgeons and clinical trial teams work in concert and where patients with conditions that have no approved therapies have meaningful options.

There, Christopher met Amon Asgharpour, M.D., and learned about a clinical trial designed to evaluate a drug therapy that could slow or reverse liver scarring.  

“Clinical trials offer patients access to emerging therapies that are potentially lifesaving and otherwise not available. Making these trials available to people like Mike is a key component of the care delivery at VCU Health,” Dr. Asgharpour said.

Christopher didn't hesitate. He underwent a biopsy to confirm his eligibility and enrolled.

Results That Speak

Over the course of the clinical trial, Christopher’s numbers began to shift. It was a blinded study, and Dr. Asgharpour cautioned that even placebo participants can sometimes improve through the lifestyle and diet changes and monitoring that come with participation. 

Mike and Pam Christopher meet with Dr. Asgharpour.
Mike (right) and Pam Christopher (left) meet with Dr. Asgharpour (center) at VCU Health. Through a clinical trial and ongoing care, Christopher saw remarkable improvements in his liver health, highlighting the promise of research-driven treatment for advanced liver disease. Photo: Daniel Sangjib Min

Christopher's results told a clear story. His liver inflammation markers dropped. The fibrotic bridging, bands of scar tissue that connect and distort the liver's normal architecture, had markedly decreased. Healthy liver tissue returned to areas once dominated by scar tissue.

By the end of the study, his disease had improved from stage 3 fibrosis to stage 1. It was the kind of result clinicians hope for and researchers work toward.

“It's a pretty impressive case to have a disease that has nothing approved to get into the trial and things get better. These are the stories I want to hear more and more of,” Dr. Asgharpour said. “And that's how we'll get there: clinical trials, pushing our field forward and engaging our patients as much as possible.”

Bridging Fibrosis and Steatosis
Bridging Fibrosis and Steatosis

Liver biopsy images from 2023 (left) and 2024 (right) show a marked reduction in fibrotic bridging and the return of healthy liver tissue during Mike Christopher's participation in a clinical trial at VCU Health.

The images, the lab values and the biopsy results were remarkable by any clinical measure. But, for Christopher, they added up to something bigger. They meant more time.

“I owe my life to the doctors and the staff,” he said.

Extra Innings

The Stravitz‑Sanyal Institute for Liver Disease and Metabolic Health is built for patients all along the liver‑health spectrum. Early concerns, quiet abnormalities and advanced disease – all of it. It’s a place where experts solve complex liver problems, and where innovative patient care is working in tandem with research to shape the future of the field.

That dual purpose matters because liver disease is common, affecting millions. Many don't understand their risk or the value of routine screening. And when disease is found, many don't realize how much more is possible in a center dedicated exclusively to advancing liver care.

“All patients across the spectrum can come here, understand their liver health, and then be plugged in to the right care,” Dr. Asgharpour said.

For Christopher, the value of his care and clinical trial isn't abstract. It can be measured in the days and years he now has to keep living the life he loves. Today, his time is defined less by treks up and down I-95 to medical appointments and more by the routines of a life he fought to keep.

Mike Christopher with his family
Bluegrass festival sign

Today, with his health improved, Mike Christopher spends time with family and enjoys traditions, including an annual bluegrass festival he hosts in Brunswick County, Va. Photos: Daniel Sangjib Min

More time in the stands at his granddaughters' softball games and watching his grandson toddle across the yard. More time for coffee with his fellow ROMEOs, short for Retired Old Men Eating Out, at the Route 1 Country Store. More time hosting an annual fall bluegrass gathering in Brunswick County. More time with Pam and his sons.

“All patients across the spectrum can come here, understand their liver health, and then be plugged in to the right care.”
— Amon Asgharpour, M.D.

Support Liver Health

Make a gift to the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. 

Give Today